FAHIM RAAFAT E F

Consejero en NABI BIOPHARMACEUTICALS · registrado desde Jan 31, 2008
Sr. VP Tech. & Prod. en NABI BIOPHARMACEUTICALS · registrado desde Dec 20, 2004

Actividad de operaciones de iniciados de FAHIM RAAFAT E F

Operaciones registradas: 42; desde Feb 2, 2004

Compras en el mercado: 3; $53.8K

Ventas en el mercado: 8; $122.7K

Empresas operadas: 1; última notificación Apr 5, 2011

Cifras calculadas a partir de notificaciones regulatorias oficiales — .

Empresas donde FAHIM RAAFAT E F ha operado

NABI BIOPHARMACEUTICALS42 ops. · $305.3K · Apr 5, 2011

Historial de resultados de FAHIM RAAFAT E F

Historial insuficiente para un historial de resultados estadístico (menos de 5 compras en el mercado).

Historial de operaciones de FAHIM RAAFAT E F

Co-iniciados de FAHIM RAAFAT E F

Ahmad FuadNABI BIOPHARMACEUTICALS
ANIDO ARMANDONABI BIOPHARMACEUTICALS
ARMISTICE CAPITAL, LLCNABI BIOPHARMACEUTICALS
Armistice Capital Master Fund Ltd.NABI BIOPHARMACEUTICALS
Aryeh JasonNABI BIOPHARMACEUTICALS
Azzarello PeterNABI BIOPHARMACEUTICALS
Bell Paul RonaldNABI BIOPHARMACEUTICALS
Berg Edward BNABI BIOPHARMACEUTICALS
Boyd StevenNABI BIOPHARMACEUTICALS
BREITMEYER JAMES BNABI BIOPHARMACEUTICALS
CASTALDI DAVID LNABI BIOPHARMACEUTICALS
Cherrington Julie MNABI BIOPHARMACEUTICALS
Clark RichardNABI BIOPHARMACEUTICALS
COLONNESE MARK PNABI BIOPHARMACEUTICALS
Cook Peter ChapmanNABI BIOPHARMACEUTICALS
COX GEOFFREY FNABI BIOPHARMACEUTICALS
Cummings James F.NABI BIOPHARMACEUTICALS
DAVIS PETER BNABI BIOPHARMACEUTICALS
Davis Todd CNABI BIOPHARMACEUTICALS
DOUGHERTY MICHAEL RNABI BIOPHARMACEUTICALS
Dunne Michael W.NABI BIOPHARMACEUTICALS
EBRIGHT GEORGE WNABI BIOPHARMACEUTICALS
Echerd MargaretNABI BIOPHARMACEUTICALS
Errington JefferyNABI BIOPHARMACEUTICALS
Finney KevinNABI BIOPHARMACEUTICALS
Finney Michael J.NABI BIOPHARMACEUTICALS
Floroiu Cezar AndreiNABI BIOPHARMACEUTICALS
Fox JamesNABI BIOPHARMACEUTICALS
Grasman Jeroen NicolaasNABI BIOPHARMACEUTICALS

Esta página republica notificaciones regulatorias públicas.

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Otro	3,023	4.30 USD	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Venta	-13,283	5.76 USD	$76.5K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Otro	3,096	4.20 USD	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Asignación	50,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	AsignaciónD (derivado)	150,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jan 7, 2011	Venta	-3,181	5.65 USD	$18K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Otro	5,404.28	2.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	AsignaciónD (derivado)	125,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Otro	5,404.28	2.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Asignación	50,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 3, 2009	Asignación	45,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 3, 2009	AsignaciónD (derivado)	115,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	Asignación	45,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	AsignaciónD (derivado)	115,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	Otro	3,833.11	3.39	$13K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-2,725	3.76	$10.2K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-2,100	3.75	$7.9K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-200	3.77	$754	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-400	3.78	$1.5K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-1,825	3.75	$6.8K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-250	3.77	$942.5	SEC
NABI BIOPHARMACEUTICALS	Jan 31, 2008	Otro	2,946.84	4.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Jan 24, 2008	Asignación	50,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Jan 24, 2008	Asignación	7,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	May 22, 2007	AsignaciónD (derivado)	90,000	0.00	—	SEC

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Otro	3,023	4.30 USD	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Venta	-13,283	5.76 USD	$76.5K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Otro	3,096	4.20 USD	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	Asignación	50,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2011	AsignaciónD (derivado)	150,000	0.00 USD	—	SEC
NABI BIOPHARMACEUTICALS	Jan 7, 2011	Venta	-3,181	5.65 USD	$18K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Otro	5,404.28	2.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	AsignaciónD (derivado)	125,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Otro	5,404.28	2.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Apr 5, 2010	Asignación	50,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 3, 2009	Asignación	45,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Apr 3, 2009	AsignaciónD (derivado)	115,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	Asignación	45,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	AsignaciónD (derivado)	115,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Feb 9, 2009	Otro	3,833.11	3.39	$13K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-2,725	3.76	$10.2K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-2,100	3.75	$7.9K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-200	3.77	$754	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-400	3.78	$1.5K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-1,825	3.75	$6.8K	SEC
NABI BIOPHARMACEUTICALS	Mar 7, 2008	Venta	-250	3.77	$942.5	SEC
NABI BIOPHARMACEUTICALS	Jan 31, 2008	Otro	2,946.84	4.41	$13K	SEC
NABI BIOPHARMACEUTICALS	Jan 24, 2008	Asignación	50,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	Jan 24, 2008	Asignación	7,000	0.00	—	SEC
NABI BIOPHARMACEUTICALS	May 22, 2007	AsignaciónD (derivado)	90,000	0.00	—	SEC